Referências: 1. Schindler ae, campagnoli c, druckmann r, huber j, pasqualini jr, scweppe kw et al. Classification and pharmacology of progestins. Maturitas 2003; 46 suppl 1:s7s16. 2. Kuhl h. Pharmacology of estrogens and progestogens: influence of different routes of administration. Climateric 2005; 8 suppl 1:363. 3. Bula do produto utrogestan® 4. Ims health midas database mat q3/2018 (vendas a preço fábrica). 5. Czajkowski k, sienko j, mogilinski m, bros m, szczecina r, czajkowska a. Uteroplacental circulation in early pregnancy complicated by threatened abortion supplemented with vaginal micronized progesterone or oral dydrogesterone. Fertil steril 2007; 87:6138. 6. Wahabi, h. A., fayed, a. A., esmaeil, s. A., & bahkali, k. H. (2018). Progestogen for treating threatened miscarriage. Cochrane database of systematic reviews, (8). 7. Haas, d. M., hathaway, t. J., & ramsey, p. S. (2018). Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology. Cochrane database of systematic reviews, 10(10). 8. Stephenson md, et al. Luteal start vaginal micronized progesterone improves pregnancy success in women with recurrent pregnancy loss. Fertil steril. 2017. 9. De lignieres, b., dennerstein, l., & backstrom, t. (1995). Influence of route of administration on progesterone metabolism. Maturitas, 21(3), 251257. 10. Tavaniotou, a., smitz, j., bourgain, c., & devroey, p. (2000). Comparison between different routes of progesterone administration as luteal phase support in infertility treatments. Human reproduction update, 6(2), 139148. 11. Ruan x, & ao, m. (2015). Systemic progesterone therapyparenteral, oral vaginal and even transdermal? J. Reproduktionsmed. Endokrinol (vol. 12). 12. Bulletti, c., de ziegler, d., flamigni, c., giacomucci, e., polli, v., bolelli, g., & franceschetti, f. (1997). Targeted drug delivery in gynaecology: the first uterine pass effect. Human reproduction, 12(5), 10731079. 13. Bjuresten, k., landgren, b. M., hovatta, o., & stavreusevers, a. (2011). Luteal phase progesterone increases live birth rate after frozen embryo transfer. Fertility and sterility, 95(2), 534537. 14. Shah, d., & nagarajan, n. (2013). Luteal insufficiency in first trimester. Indian journal of endocrinology and metabolism, 17(1), 44. Https://doi.org/10.4103/22308210.107834 15. Medley, n., vogel, j. P., care, a., & alfirevic, z. (2018). Interventions during pregnancy to prevent preterm birth: an overview of cochrane systematic reviews. Cochrane database of systematic reviews, 11, cd012505. 16. Druckmann r, druckmann ma. Progesterone and the immunology of pregnancy. J steroid biochem mol biol. 2005; 97:38996. 17. Lopezcastejon a, m.c. f. (2004). Hemorragia uterina disfuncional de la adolescencia y su tratamiento con prosterona micronizada. Toko ginecologia pratica, 63(4), 315319. 18. Shangold mm, tomai tp, cook jd, jacobs sl, zinaman mj, chin sy et al. Factors associated with withdrawal bleeding after administration of oral micronised progesterone in women with secondary amenorrhea. Fertil steril 1991; 56(6):10401047 19. Pinkerton joann v. Et al. The 2017 hormone therapy position statement of the north american menopause society. 2017; 24(7); 728753. 20. Rhoda h. Cobin et al. American association of clinical endocrinologists and american college of endocrinology position statement on menopause2017 update. 2017; 23(7); 869880.